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Abstract
: Death rates from cardiovascular disease in Russia are amongBackground
the highest in the world. In recent years, the Russian government has invested
substantially in the healthcare system, with a particular focus on improving
access to advanced technology, especially for acute myocardial infarction
(AMI). This protocol describes a study to understand the management of AMI in
different Russian regions, investigating the role of patient, clinical, and health
system characteristics.
 A prospective observational study has recruited a representativeMethods:
sample of AMI patients within 16 hospitals from 13 regions across Russia.
Criteria for inclusion are being aged 35-70 years with a confirmed diagnosis of
AMI and surviving until the day after admission. Information being collected
includes health system contacts and features of clinical management prior to
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includes health system contacts and features of clinical management prior to
the event and in the 12 months following discharge from hospital. Following
initial exploration of the data to generate hypotheses, multivariate analyses will
be applied to assess the role of these characteristics in both treatment
decisions and any delays in time critical interventions. Between June 2015 and
August 2016, 1,122 patients have been recruited at baseline and follow-up to
12 months post-discharge is scheduled to be completed by autumn 2017. The
study is unique in examining patient factors, clinical management prior to
admission and in hospital in the acute phase and throughout the critical first
year of recovery across a diverse range of geographies and facilities. It uses
standardized instruments to collect data from patients and health care
providers and includes regions that are diverse in terms of geography and
development of cardiology capacity. However, given the limited health services
research capacity in the Russian Federation, it was not possible to obtain a
sample that was truly nationally representative.
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Introduction
The Russian Federation has one of the highest burdens of cardi-
ovascular disease (CVD) in the world1, an important cause of its 
low life expectancy at birth, only 70.5 years in 2015 according to 
the World Health Organization. There are many potential reasons 
for the very high CVD rates, spanning the entire causal pathway, 
from underlying social determinants of health2 through proximal 
risk factors such as smoking, diet, hazardous alcohol consump-
tion3, to weaknesses in the health care system4. Consequently, a 
comprehensive response requires actions at all levels. In this study, 
we focus our attention on the contribution of the health system.
Although the Soviet Union initially placed a high priority 
on health, a combination of economic weakness5, isolation from 
international developments6, and the considerable challenges of 
delivering modern healthcare to a vast country, meant that the 
system inherited by the newly independent Russian Federation 
lagged behind that in many western countries. The scale of 
the challenge was illustrated by a study that compared levels of 
mortality amenable to health care, which showed that the 
sustained improvements seen in the west after the mid-1960s were 
not achieved in the Soviet Union4.
Although the inherited system was extensive and well-staffed 
in comparison to other middle-income countries, it struggled 
initially to adopt the rapid advances that were taking place in 
medical science, especially in areas such as the management of 
acute myocardial infarction(AMI), which elsewhere was being 
transformed by the introduction of thrombolysis and percutaneous 
transluminal coronary angioplasty (PTCA)7,8.
These concerns attracted official recognition in 2005 when a 
national priority project was announced to improve population 
health9. This had several elements, including better access to high-
quality health care, a renewed emphasis on prevention in the health 
care system, strengthened primary care, and greater provision of 
advanced medical technology. A further goal to reduce mortal-
ity from cardiovascular diseases was added in 200810. This was 
supported by greater funding for salaries of health professionals 
and new equipment. Forty-five percent of the additional funding 
was allocated to advanced medical technology9. This has been 
associated with a marked increase in utilisation of such technol-
ogy, including PTCA. Yet it is recognised that that outcomes of 
myocardial infarction still lag behind those in Western countries, 
although the reasons are not fully understood.
Previous research has used data from a large federal registry, 
recording details of patients presenting with acute coronary 
syndrome (ACS) to a network of participating hospitals11,12. 
However, while providing some valuable insights, results have 
been limited as data are collected only on the management of 
patients in hospital, while it is now recognised that pre- and 
post-hospital care, including early thrombolysis and secondary 
prevention also play important roles in reducing mortality13.
There is a clear need to document in detail the management 
of patients presenting with AMI across Russia. Information is 
needed on the entire patient experience, from onset of symptoms, 
through to the phase of acute care to the long-term management 
and treatment they receive once they have been discharged. This 
should describe how they are treated, by whom, and whether 
there are any delays in obtaining treatment, especially at those 
points in the patient journey that are time-critical events. It should 
assess whether the treatment provided complies with accepted 
good practice and assess where problems are found, and iden-
tify plausible reasons that can be addressed by changes to policy 
and practice. Here we present the protocol for a study we are 
undertaking that does this in hospitals across diverse regions of 
the Russian Federation. This is part of a large international project 
seeking to understand the reasons for the high levels and poor 
outcomes of CVD in Russia.
Methods and study design
The objective of this paper is to describe the context and design 
of a study of the management of acute myocardial infarction in 
Russian hospitals.
Objectives of the study itself
a)   To describe current treatment of AMI in different regions of 
Russia and in different types of medical facilities accepting 
patients with AMI, comparing observed practice with that 
recommended in Russian14 and European guidelines15 so as to 
identify barriers to effective treatment and continuity of care 
at different stages of the patient journey - prior to admission, 
      Amendments from Version 1
According to the referees’ comments we have changed the study 
goal, legend of Supplementary File 1, and added columns to 
Table 1 to give more comprehensive characteristics of the clinics 
participating in the study, including N of beds.
We estimated number of patients that would be admitted in a 
6 month period (ignoring seasonal variation) in the clinics and 
put this data in the Table 2. We have now calculated the number 
recruited as a percentage of this figure. This ranges from 9% to 
87% and is now shown in an additional column (last column on 
the right) in Table 2.
We added the data on the thrombolysis in the text clarifying that 
those 4 clinics which did not have PCI facilities were able to 
perform TL. 
Table 2 was also revised, and footnotes explanations were added.
Some clarifications of the planned statistical analysis were 
provided. 
Some clarification on Box 3 regarding the role and level of the 
policlinic cardiologists was added. 
New table with mean (and SD) age was added (Table 3). 
The point that MI treatment is based on the Federal clinical 
guideline approved by Ministry of health in 2013 is added in the 
text. 
See referee reports
REVISED
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within the hospital, and following discharge to polyclinic 
cardiologists and general physicians.
b)   To describe and, where possible, explain differences in 
management of patients defined by gender, socio-economic 
position, and distance from facilities.
c)   To propose changes to policy and practice that will remove 
barriers to effective and timely treatment for all.
The study is, to our knowledge, the first ever study in different 
parts of Russia describing the pathway followed by patients with 
AMI. It is thus primarily hypothesis generating, although some 
testing will be possible. It is observational and seeks to recruit 
a representative sample of patients presenting with AMI at 
16 hospitals in 13 Russian regions and who survive at least until 
the morning after admission. Data are collected on both the index 
admission and any encounters with the health system in the preced-
ing 12 months and follow up at 6 and 12 months after discharge.
Study population and recruitment
The target population is men and women aged 35–75 years, admit-
ted to a hospital or cardiology centre with a presumed diagnosis of 
AMI that is subsequently confirmed and who survive until the day 
following admission, including those who subsequently die in 
hospital and those who are discharged alive. Patients hospitalized 
in any department or ward with a primary diagnosis of AMI 
were eligible. The age range was selected for consistency with a 
major population-based study which we are also conducting look-
ing at aetiological factors and treatment in the Russian cities of 
Arkhangelsk and Novosibirsk. As noted above, current life 
expectancy at birth (both sexes combined) in Russia is 70.5 years.
As this study seeks to capture the actual management of patients 
diagnosed as having an AMI, we have not imposed uniform diag-
nostic eligibility criteria. Instead we accepted the criteria for AMI 
used in each centre. These nevertheless all included standard ECG 
changes and cardiac enzymes (creatinine phosphokinase as mini-
mum). Where they differ was in the use of troponin assays, with 
the precise version varying. In analyses of the completed dataset, 
we will explore the extent to which any observed differences in 
diagnostic criteria impact on which patients are offered treatment, 
taking as our reference the most inclusive criteria observed in any 
facility.
The overall inclusion and exclusion criteria are summarized in 
Box 1.
For each facility, recruitment was staggered over the course of 6–9 
months. Data are collected by staff and medical students in each 
centre. However, they have limited time available to do this work, 
so it was determined that it was feasible for a maximum of 1 patient 
each day to be recruited. The study timeline is presented in Box 2.
Box 1. Inclusion and exclusion criteria
Inclusion criteria
•      Acute admissions with a presumed diagnosis of 
AMI subsequently confirmed by the morning after 
admission.
•     Age 35–75, male or female
•      Living in the oblast/republic in which the hospital 
is situated (to enable access to previous medical 
records)
•     Survived until the day after admission
Exclusion criteria
•      Participating in clinical trials where this is known at the 
moment of inclusion, as they are likely to be receiving 
atypical treatment.
•      Patients, referred from another facility if they have 
already spent more than 24 hours in it.
•      AMI occurring in hospital following a surgical 
procedure
Box 2. Study timeline
Study stage Period
Recruitment to the study/
hospital stage June 2015–August 2016
6 months follow up December 2015–February 2917
12 months follow up July 2016–September 2017
Data analysis and publications October 2017–February 2019
In order to recruit as representative sample of AMI cases as 
possible, the following procedure was used. Within the recruit-
ment period, a list of random dates and times was generated by 
the central study coordination team, constrained so that, for each 
facility, none could occur on the same day. On a daily basis, in 
each facility, the list of all patients admitted during the previous 
day with a confirmed diagnosis of AMI was compiled. The patient 
to be recruited was selected from this list as the first to be admit-
ted following the randomly selected date and time. If this 
patient could not be recruited, the next patient in order of admis-
sion was approached until for that day a patient was enrolled in 
the study. The recruitment process is summarised in Figure 1.
When approached by the study team, a patient was given 
a verbal explanation of the study, including the importance of 
follow up, and given an information leaflet. Signed informed 
consent was sought.
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Figure 1. Recruitment procedure used in the study of management of  acute myocardial infarction in Russian Federation.
Selection and characteristics of facilities
Patients have been recruited from hospitals in 13 regions across 
the Russian Federation. Ideally, we would have employed a large, 
randomly selected sample of facilities but this was not practical as 
infrastructure for undertaking such research in Russia, including 
clinicians with relevant research skills, is limited. Consequently, 
it was necessary to draw a convenience sample, identifying clini-
cians willing to participate. It is recognised that the settings cannot 
be entirely representative of the country as the study centres are 
mainly from European part of the Russian Federation, with few 
from Siberia. In particular, two are from some of the wealthiest 
regions, benefitting from large oil and gas reserves, but with a sparse 
population. However, judged in terms of penetration of advanced 
treatment, in this case the rate of PTCA per 100,000 popula-
tion, these regions span almost the entire range seen in the 
country (Supplementary File 1, unadjusted crude rates). We explic-
itly included some small facilities, even though they have limited 
capacity to intervene. We considered this important to capture as 
much of the spectrum of treatment, as experienced by patients, 
as possible. The names and locations of participating centres 
are shown in Figure 2.
A standardized form was completed describing basic informa-
tion on capacity and activity in each facility. In most cases, the 
study included a single facility in each region. The exceptions 
are Samara region (3 facilities) and Tver (2 facilities). Five facili-
ties (31.3%) serve cities (municipal hospitals) and 11 (68.8%) 
are regional facilities. Half are specialized cardiology hospitals 
and half are general hospitals with cardiology departments.
All facilities can measure troponin or CK-MB measurements 
at all times of the day and night. Among them, 10 (62.5%) 
measure troponin I, 5 (31.3%) Troponin T, 5 (31.3%) high 
sensitivity Troponin I, 2 (12.5%) high sensitivity Troponin T and 
13 (81.3%) CK-MB. Echo facilities are available 24 hours and 
7 days per week in 9 facilities (56.3%) and in working hours 
only, Monday-Friday in 7 (43.8%).
Twelve (75%) of the facilities can perform PTCAs, all 24 hours 
a day; the remaining four are two small municipal hospitals in 
Samara, the regional cardiology hospital in Bryansk and one of the 
hospitals in Tver, all of which are able to perform thrombolysis). 
The mean monthly number of PCTA procedures per interventional 
cardiologist is 39 (minimum 3, maximum 170). None of the hospi-
tals in this study offer open cardiac surgery.
Nine of the facilities include a rehabilitation department on the 
same site. All others use separate sanatoria.
Table 1 reports data on activity in the 13 facilities information, 
and was available derived from returns of the hospitals to the 
Federal Ministry of Health. This provides contextual data on these 
hospitals, by calendar year, indicating both the size of the hospital 
and the total number of patients with an MI. As is apparent, there 
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Figure 2. Location of participating centres in the management of  acute myocardial infarction in Russian Federation.
is considerable variation in levels of activity, patient characteris-
tics and patient outcomes across these 13 hospitals. For example, 
the proportion of patients with AMI admitted within 24 hours 
of symptoms ranges from 28.4% to 92.5%.
Data collection
Data are collected from patient interviews at three points: dur-
ing index admission, at 6 months and at 12 months following 
discharge. Information is also extracted from medical records 
with respect to the index admission and contacts with the health 
system in the 12 month period preceding admission and following 
discharge, at both the hospital and the polyclinic that the patient 
attends (Figure 3). All deaths reported during the 12 months of 
follow up are verified.
The information collected is designed to shed light on a series 
of decisions made by both patient (and their family) and health 
care providers, along the clinical pathway. These decision points 
arise at every stage of the patient journey, from when the patient 
develops symptoms, such as whether they recognize the need 
to seek help, to the decision by the physician responsible for 
follow up to prescribe secondary prevention medication.
Management
The co-ordinator at each site, a practicing cardiologist, is 
responsible for oversight of the project and recruiting a team 
of interviewers, who are provided with written guidance on 
the conduct of the study and have received training, co-ordinated 
from Moscow, via Skype. Most of the data are being entered into 
a specially designed template created in Microsoft on Access™. 
However, the 12 month data are being entered using a bespoke 
data entry interface based on SURVANT [http://www.survant.net]. 
The data are checked by the study co-ordinator in Moscow. Data 
analysis will be conducted using the Stata 14.
Piloting
The study was piloted in 3 study centres in the spring 
of 2015, involving all stages of the study. In each centre, a group 
of 5 patients who were at that point in hospital and two groups 
of 5 patients each who had been hospitalised in a designated 
week 6 and 12 months previously were included. For these 
subjects, questionnaires were completed as was abstracting of 
medical records. The pilot results were used to refine the study 
documentation and standard operating procedures. Patients 
included in the pilots were not included in the main study.
Patient interviews
Participants are interviewed three times in person: during the 
index hospitalization and at 6 and 12 months later. A core data set 
comprises socio-demographic data, an account of events in the 
period between onset of symptoms and admission, including signs 
and symptoms, health seeking behaviour, and treatment received 
(Box 3). The questionnaires are available as Supplementary 
File 2 and Supplementary File 3. As far as possible, questions 
were consistent with those used in previous studies in Russia, 
such as the Health in Times of Transition (HITT) project15, the 
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Table 1. Treatment characteristics of clinics from 13 regions for 2015, from official statistical forms – Form 14 “Data on hospital 
performance”.
N of 
beds 
in 
clinic. 
Total;
N of 
cardiology 
beds in 
clinic
N of MI 
patients 
in the 
clinic in 
2015
Patients 
with AMI 
hospitalized 
in first 24 
hours from 
symptom 
onset
In-hospital 
mortality of 
patients with 
AMI
In-hospital 
mortality 
of patients 
with AMI 
in first 24 
hours
Percentage 
of patients 
undergoing 
PTCA (from 
those, 
hospitalized in 
first 24 hours)
Percentage of 
patents received 
thrombolysis 
(from those, 
hospitalized in 
first 24 hours)
City hospital N 1, 
Archangelsk
991 140 558 67.6% 10.9% 4.6% 61.3% 8.2%
Altay regional 
cardiology hospital, 
Barnaul
356 356 362 68.4% 8.1% 5.7% 82% 4,5%
Belgorod regional 
hospital 
1055 112 501 75.8% 2.4% 0.4% 87.8% 12.2%
Bryansk cardiology 
clinic
192 192 254 45.3% 14.6% 7.9% 0 4.3%
Kazan interregional 
clinic center, 
Tatarstan 
400 92 430 81.4% 4.7% 4.7% 81.4% 1.6%
Kemerovo 
cardiology clinic 
355 218 1032 65.0% 9.5% 4.8% 68.1% 3.9%
Perm city clinic N 4 544 77 1052 83.6% 9.1% 3.5% 66.7% 8.0%
Emergency city 
hospital, Rostov-
on-Don
845 180 1280 28.4% 10.2% 6.1% 20.5% 8.5%
Samara regional 
cardiology clinic
671 458 2220 92.5% 8.4% 4.8% 43.3% 10.3%
Tver regional 
hospital 
930 160 516 50.0% 4.8% 2.3% 78.5% 25.0%
Tver city hospital 760 345 319 66.1% 9.1% 6.0% 0 24.5%
Tuymen regional 
hospital
500 150 1100 88,7% 12.4% 4.4% 64.1% 12.0%
Khanty-Mansiysk 
regional hospital 
650 32 184 91.8% 6.0% 0.5% 62.5% 2,7%
Izhevsk Family Study16, and the Russian Longitudinal Monitoring 
Survey 717. Other survey instruments were drafted in English and 
translated into Russian.
Follow-up interviews at 6 and 12 months focus on self-reported 
treatment, medication, and contact with health services (Box 3). 
As in all surveys, there is a trade-off between the length of the 
questionnaire, and thus the amount of data obtained, and the risk 
of respondent fatigue. Thus, while there are many instruments for 
assessing adherence to medicines, looking at patterns of adherence, 
reasons for non-adherence, and barriers to adherence18, during 
piloting it became clear that an abbreviated set of questions was 
necessary. The single question “In the past month, how often did 
you take your medications as the doctor prescribed?” was used as 
it has been found to predict future cardiovascular events17. This was 
supplemented with questions to identify reasons for non-adher-
ence, including cost, belief that medicines are ineffective, and 
concerns about side effects, as well as forgetfulness. Questions on 
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Figure 3. Overview of the study design of management of  acute myocardial infarction in Russian Federation.
Box 3. Data items collected at each stage
Components of initial in-hospital interview 
Socio-economic status (education, marital status, employment, 
economic status) 
Characteristics and date and time of onset of initial symptoms 
Patient actions after appearance of initial symptoms, including 
health seeking behaviour and any delays 
Patient-reported knowledge of their medical history (e.g. 
hypertension and cholesterol levels, history of previous cardiac 
problems), visits to physicians during the previous 12 months 
and actions taken (BP and cholesterol measurement etc.)) 
Key behavioural risk factors (smoking and alcohol) 
Experience of counselling on risk factors 
Medications prescribed before hospitalization 
Patient contact details (phone, mobile, email, address)
Components of follow-up interviews and medical record extraction 
Employment and welfare status 
Any type of rehabilitation (sanatorium, polyclinic etc.), its duration 
and content (only asked at 6 months) 
Control of BP and cholesterol levels, experience of cardiac 
symptoms 
Frequency of physician consultations since discharge 
Diagnostic procedures since discharge 
Changes in smoking and alcohol habits 
Experience of counselling on risk factors 
Medications: names, doses, and frequencies. 
Changes of medications and reasons for doing so 
Availability of medications: receiving free, or paying own 
money, reasons for paying money 
Adherence to medicines
Information extracted from medical records
How the patient arrived at hospital and how long it took 
Date and time of onset of initial symptoms 
ECG results 
Troponin assay (whether conducted and results) 
Other investigations undertaken (including results), treatment 
provided following admission 
Revascularization procedures characteristics: type, date and 
time 
Blood pressure on admission 
Lipid profile and other laboratory tests 
Prior medical history 
Recommendations for follow up sent to polyclinic cardiologists 
at discharge 
*polyclinic cardiologists in Russia are general physicians with 
some specialist training in cardiology, they do not perform 
interventions
Information extracted from polyclinic medical records 
Twelve months prior to admission 
Medical history and treatment as it relates to cardiovascular 
disease 
Consultations with primary care physician in 12 months prior 
to admission: number and content 
Blood pressure and cholesterol measurements 
Recommendations given in relation to cardiovascular risk 
factors, including lifestyle modifications and medications
Twelve months following admission
Treatment recommended by general practitioner, comparison with 
recommendation from hospital and cardiologist, changes and 
reasons for changing (if recorded). 
Rehabilitation, 
BP and cholesterol measurement, 
Risk factors consultations etc.
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medications being taken were open, including the name of the 
medication, dosage and frequency. Responses were coded 
subsequently.
Hospital medical records abstraction
Information on clinical management, both within the hospi-
tal during the baseline admission and in the ambulance in which 
the patient travelled to hospital, are obtained by abstraction of 
hospital clinical records (Box 2) using a structured pro forma.
Polyclinic medical record abstraction
As the study seeks to capture events across the entire patient 
journey, additional information is obtained from the polyclinic 
that the patient normally attends. In the Russian Federation 
individuals typically receive all continuing treatment at the same 
facility, either at where they live or work. The information required 
is extracted and recorded in two separate forms. The first relates 
to the 12 months prior to baseline admission. The second covers 
the 12-month period after that admission (Box 2).
Death verification procedures
Should a patient die it will usually be notified to the health 
facilities where they are receiving treatment. However, when 
participants are asked contact details they are also asked for 
details on a close relative, to help with tracing in case they are 
lost to follow up and not reported as dying. When deaths are 
identified, we will seek to obtain a copy of the medical death 
certificate from the health facility. For logistical reasons, it is 
not possible to undertake further adjudication of cause of death. 
However, over 50% of deaths in the Russian Federation are 
subject to autopsy19, a much higher proportion than in many other 
countries.
Progress with recruitment
As of February 2017, we had completed the baseline recruit-
ment in all 13 regions (Table 2). A total of 1,126 patients have 
been recruited. The number of subjects from each region varied 
from 12 to 128. The table also presents the number of patients 
who were hospitalized in 2015 with an AMI. The mean ages of 
subjects in each hospital are shown in Table 3. There is consider-
able variation in the proportion of patients who were dead on arrival 
or within 24 hours and among those who survived who agreed to 
participate across hospitals. 935 subjects have completed the 
6-month questionnaire (83.0% response rate), 29 died within 
this 6-month period with 129 lost to follow up and 29 refused 
to participate.
Analysis
This is, to our knowledge, the first attempt to understand the 
actual practice and management of AMI in the Russian 
Federation in both the acute phase in the critical year follow-
ing the event using standardized methods. As such, the analysis 
will be exploratory, seeking to describe the extent of variation 
across a wide range of institutions in the case mix treated in 
each facility, including distances travelled to gain admission, 
and processes of care, such as investigations and treatments. We 
will also look at differences in diagnostic criteria or thresholds 
for diagnosing an AMI. Subsequent analysis will examine health 
seeking behavior, prior to the episode leading to admission, 
during that episode, and over the 12 months following the MI. 
This will include issues such as adherence to medicines and its 
determinants.
These exploratory analyses will generate a series of hypotheses that 
can be explored subsequently. For example, these could include 
testing hypotheses that patients are less likely to be treated with 
PTCA if they have certain characteristics. Thus, illustrative ques-
tions for analyses will include whether the patient’s gender or 
employment status influence their decisions in seeking care, found 
in research elsewhere, where men tend to disclose their symp-
toms as a means to receive help, whereas women tend to wait for 
others to discover their symptoms18. Or do these characteristics 
influence clinical decisions, with patients who have certain char-
acteristics treated differently? There are now many studies from 
other countries showing that, after taking account of differences 
in clinical features, older people19 and women20,21 presenting with 
AMI are less likely to receive active treatment. Although all the 
facilities undertaking PTCA provide a 24-hour service, are there 
differences in management according to time of day, as has been 
found elsewhere, with differences in both case-mix and 
outcomes?22 
In testing such hypotheses, analysis will take account of the 
hierarchical structure of the data, with patients nested within 
facilities. Thus, where possible we will use multilevel models to 
take account of clustering of patients into hospitals and of hos-
pital characteristics through the introduction of a random inter-
cept (for the hospital)23. These models will examine patient-level 
characteristics, such as distance from facility, gender and educa-
tion, clinical characteristics, such as presenting symptoms or signs, 
and facility-level characteristics, introduced as fixed effects. Where 
appropriate, analysis will be stratified, for example by facilities 
offering PTCA or not.
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Table 2. Recruitment of patients to the study.
Estimated 
number of 
patients 
admitted 
with MI 
in six 
months †
Potentially 
eligible 
patients 
during 
recruitment 
period 
(based on 
eligibility 
scheme)
Died before 
first contact*
Not meeting 
inclusion 
criteria**
Refused to 
participate***
Informed consent 
signed
N
% of 
potentially 
eligible 
patients 
recruited
N
% of 
potentially 
eligible 
patients 
recruited
N
% of 
potentially 
eligible 
patients 
recruited
N
% of 
potentially 
eligible 
patients 
recruited
% of all 
patients 
with MI 
admitted 
during 
recruitment
City hospital No 1, 
Archangelsk 294 89 0 0,0 12 13,5 11 12,4 66 74,2 22.4%
Altay regional 
cardiology 
hospital, Barnaul 
181 93 1 1,1 0 0,0 31 33,3 61 65,6 33.7%
Belgorod regional 
hospital 250.5 105 2 1,9 0,0 7 6,7 96 91,4 38.3%
Bryansk cardiology 
clinic 127 77 4 5,2 0 0,0 2 2,6 71 92,2 55.9%
Kazan interregional 
clinic centre 215 154 5 3,2 7 4,5 15 9,7 127 82,5 59.1%
Kemerovo 
cardiology clinic 516 149 8 5,4 3 2,0 18 12,1 120 80,5 23.3%
Perm city clinic N 4 526 150 6 4,0 19 12,7 5 3,3 120 80,0 22.8%
Emergency city 
hospital, Rostov-
on-Don
640 173 4 2,3 79 45,7 13 7,5 77 44,5 12.0%
Tver regional 
hospital 258 88 0 0,0 37 42,0 22 25,0 29 33,0 11.2%
Tver city hospital 159.5 38 6 15,8 2 5,3 2 5,3 28 73,7 17.6%
Saratov Regional 
cardiology hospital 22 3 13,6 0 0,0 7 31,8 12 54,5
Samara regional 
cardiology clinic 1110 108 6 5,6 1 0,9 1 0,9 100 92,6 9.0%
Kinel rural hospital 
(Samara region) 21 0 0,0 0 0,0 0 0,0 21 100,0
Otradny rural 
hospital (Samara 
region)
7 0 0,0 0 0,0 0 0,0 7 100,0
Tuymen regional 
hospital 550 149 6 4,0 13 8,7 19 12,8 111 74,5 20.2%
Khanty-Mansiysk 
regional hospital 92 96 7 7,3 0 0,0 9 9,4 80 83,3 87.0%
Total ___ 1519 58 3,8 173 11,4 162 10,7 1126 74,1
* It is the patients who was considered eligible on the second day after hospitalization and for whom the task form were filled, but who died before first contact in the 
hospital (on the 2d or third and so on day of hospitalization, but not in 24 hours)
** It is mainly the patients for whom the initial diagnosis of MI was changed after 24 hours on other (angina and so on) and some special situation, when its was 
realized that eligible patient is a prisoner and it was decided after the consultation with central team to exclude him as follow up will not be possible.
*** It is eligible patients which fit to inclusion criteria but which refused to participate in the study during the first contact and did not signed the informed consent
† Estimated from annual total of admissions with myocardial infarction (all ages)
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Table 3. Mean (standard deviation) age in years of study participants in 
each region.
Region Males Females Total
Barnaul 57,6 ( 49,2 - 66,1) 65,6 ( 59,7 - 71,5) 60,1 ( 51,6 - 68,6)
Archangelsk 59,8 ( 52,1 - 67,5) 60,8 ( 52,6 - 69,0) 60 ( 52,2 - 67,7)
Belgorod 56,4 ( 47,4 - 65,3) 62,7 ( 54,6 - 70,8) 57,0 ( 48.0 - 66,1)
Bryansk 58,9 ( 51,1 - 66,6) 61,9 ( 55,8 - 67,9) 59,7 ( 52,3 - 67,1)
Kemerovo 56,8 ( 49,6 - 63,9) 61,4 ( 56,2 - 66,5) 57,9 ( 50,9 - 64,9)
Perm 58,3 ( 50,3 - 66,3) 62,4 ( 57,4 - 67,4) 59,2 ( 51,6 - 66,8)
Kazan 55,9 ( 47,4 - 64,5) 62,9 ( 55,8 - 70,0) 57,3 ( 48,6 - 66,0)
Rostov 59,0 ( 51,5 - 66,6) 60,9 ( 56,0 - 65,8) 59,5 ( 52,4 - 66,5)
Samara 57,9 ( 50,5 - 65,3) 61,2 ( 53,9 - 68,6) 58,8 ( 51,3 - 66,3)
Saratov 58,6 ( 52,1 - 65,1) 63,3 ( 59,8 - 66,8) 59,8 ( 53,6 - 65,9)
Tver 57,9 ( 51,3 - 64,5) 57,5 ( 52,1 - 62,9) 57,8 ( 51,4 - 64,3)
Tuymen 57,1 ( 48,7 - 65,5) 64,4 ( 59,1 - 69,8) 59,5 ( 51,3 - 67,8)
Khanty-Mansiysk 54,9 ( 45,6 - 64,1) 63,4 ( 56,3 - 70,4) 56,3 ( 46,9 - 65,7)
Total 57,4 ( 49,4 - 65,5) 62,4 ( 56,1 - 68,7) 58,5 ( 50,6 - 66,5)
Discussion
This study will, for the first time, provide detailed information on 
the AMI management in the Russian Federation, tracing the entire 
patient pathway and identifying variations in treatment, includ-
ing both rates and delays, thereby elucidating barriers to effective 
management. Although it cannot claim to be nationally representa-
tive, it includes hospitals that span the entire spectrum of manage-
ment in the Russian Federation, as judged by intervention rates. 
While recognising that the facilities we include may represent some 
of the better hospitals and clinics, in terms of staffing and facilities, 
our findings will still be of value. In this situation, they will provide 
an “upper” bound to the type and quality of care available to 
the bulk of the Russian population, at least outside of the large 
metropolitan centres of Moscow and St Petersburg.
There are some other sources of data on the management of AMI 
in Russia, including a federal registry, established in 2008 and 
including 213 clinics in 36 centres13. We will draw on these data to 
supplement our interpretation of what we find. However, the fed-
eral registry includes only data on the index hospital stay and has 
several methodological problems, such as a lack of clear recruit-
ment procedure and considerable missing data. Another source is a 
series of RECORD studies, collecting data on patients with 
acute coronary syndrome (ACS). The most recent, RECORD 3, 
was performed in the first 6 months of 2015 and included 
2370 patients from 47 clinics. All patients with ACS hospitalized 
in the participating clinics in a single 1 month are recruited and 
although there is follow up over twelve months, these data are not 
available. Russian investigators also participate in the CLARIFY 
study24, and have recruited 2,200 patients from across the country, 
but this collects different information than in the present study and 
included patients with stable forms of coronary heart disease.
Our study has strengths and weaknesses. First, although we can 
make no claim to be nationally representative, we do include 
a range of facilities in which AMI patients are treated and not 
only regional and academic centres. Moreover, we used a 
procedure to randomly select patients within facilities, this 
minimising the influence of subjective judgements that might 
have led to biases in the profile of cases. Second, we collect 
extensive data on pathways to care and follow-up not available 
elsewhere, including information that will enable us to gain 
insights into the reasons for any observed variations. However, 
we do not cover the entire country. In addition, our sample is 
based on willingness of cardiologists to participate. There is little 
tradition of clinician involvement in health services research in 
Russia, although we hope that this study will act as a catalyst to 
change this25.
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3. It is unclear, what is the proportion of potentially eligible AMI patients to all AMI patients in these
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4. Box 1. Inclusion and exclusion criteria: The exclusion criterion “Patients, referred from another
facility…” is not self-explanatory for the readers who do not know the Russian health care system. Why
exclude referred patients if the objective is to explore treatment pathways. Information on the (estimated)
proportions of the patients included /exluded of the total AMI patient would be helpful, as well.
 
5. Box 2. Study timeline: In the end date of the 6 months follow-up, there is an obvious mistake (Dec
2917).
 
6. Figure 1 – an extra comma ”,” in the description of Selection.
 
7. Page 5. What are the facilities for these four hospitals to perform PTCAs (which were not able to
perform PTCAs 24h)?
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 perform PTCAs 24h)?
 
8. Table 1. Although this table describes the overall characteristics of these hospitals and not information
on the study population, it would be informative to know the number of AMI patients in these hospitals. We
recommend stating more clearly that this table does not describe the study population. It should be stated
if the percentage of patients undergoing PTCA in this table refers to these AMI patients hospitalized in first
24 hours from symptom onset or if it is the overall proportion of performed PTCAs of all AMI or CHD
patients.
 
9. Figure 3. The second box in the lower row: policlinic or polyclinic
 
10. Table 2. This table would benefit from some revision. It is somewhat confusing since there are
numbers and percentages in disorder although it is mentioned in the column label. Perhaps percentage
sign would clarify this.
 
The definitions of the categories “not meeting inclusion criteria”, “refused to participate”, and “died before
first contact” are unclear:
If a potentially eligible patient has died before the first contact, why he/she is not categorized as a
“not meeting inclusion criteria” patient (one of the inclusion criteria)?
I understand these columns so that “not meeting inclusion criteria” and “refused to participate can
be nested in some cases (Barnaul, Tuymen, Khanty-Mansiysk) or are the values incorrect for these
hospitals? (Tuymen: 6+13+20+112=151, not 149)
 
Values for Barnaul do not tally (93*0.667=62 NOT 55).
 
11. Page 8, Progress with recruitment “The number from each region varied from 12 to…”. We suppose
the correct number is 7.
 
12. Analysis. Planned statistical methods to analyse this data are described only in the Abstract. We are
concerned whether the number of this dataset will be enough for the multilevel modelling. There are only
7 cases in one region and 12 in the other and the number of covariate variables is large. Have you done
some preliminary analyses to ensure that multilevel modelling is feasible?
 
 No competing interests were disclosed.Competing Interests:
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard, however we have significant reservations,
as outlined above.
Author Response 18 Mar 2018
, therapy, Ivanovo state medical academy, Russian FederationAnna Kontsevaya
1. Methods and study design / Objectives. We suggest that the overall objectives of the large study
and objectives of this paper are clearly separated. Now the objectives describe mainly the aims of
the large study and the aims of this paper remain indistinct.
Response: the objectives of the study have now been added to the text and a clear
distinction between the larger study and paper objectives made (page 4 line 14)
 
 2. Supplementary File 1. How the rate is calculated? Is it a crude or age-adjusted rate? It is
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  2. Supplementary File 1. How the rate is calculated? Is it a crude or age-adjusted rate? It is
necessary to take into account the varying age differences between the regions. We do not fully
understand these figures. Without any further explanation, the figure in the file seems to suggest
that 55% of the population have undergone a PTCA in one region, which does not sound plausible.
Or is the population somehow fixed, i.e. not the total population of the corresponding age group?
The variation between the regions is also huge. We suggest explaining these differences at some
extent. How accurate is the data from the official statistics?
Response: We thank the reviewer for pointing out an error in that the wrong graph was
uploaded. This has now been corrected. The figures are the crude unadjusted rates (per
100 000 of population). These data are collected by regional health administrators and are
believed to be accurate as they are the basis for payment and are carefully audited.
However, it is not possible to calculate directly or indirectly standardized rates as they are
not broken down by age. 
 
3. It is unclear, what is the proportion of potentially eligible AMI patients to all AMI patients in these
facilities. It is important to know the (rough) estimate of the random sampling.
Response: We did not systematically collect data on all patients admitted during the
recruitment period. However, we do have information on the number of patients with MI
admitted in 2015 and, from that, can estimate the number that would be admitted in a 6
month period (ignoring seasonal variation). We have now calculated the number recruited
as a percentage of this figure. This ranges from 9% to 87% and is now shown in an
additional column (last column on the right) in Table 2, for the 13 hospitals from which
data from the Ministry of Health were available. 
 
4. Box 1. Inclusion and exclusion criteria: The exclusion criterion “Patients, referred from another
facility…” is not self-explanatory for the readers who do not know the Russian health care system.
Why exclude referred patients if the objective is to explore treatment pathways. Information on the
(estimated) proportions of the patients included /exluded of the total AMI patient would be helpful,
as well.
Response We agree that a comprehensive assessment would include such patients.
However, we faced several constraints. Most importantly, we did not have the capacity (in
terms of trained clinicians willing to make the non-trivial commitment to participate and
manage data collection in their hospitals) to include all hospitals in each region. This
meant that we could not follow the entire pathway for all patients so we had to decide a
point at which they entered the hospital system. We decided that this would most
appropriately be their first admission to any hospital or a referral within 24hrs of the index
event from another facility. By including a small number of rural hospitals, we then could
begin to understand what types of patients are referred onwards to these larger centres,
thus getting at least some idea about this group. Unfortunately, we do not have precise
information on patients referred over 24 hours after the index event. However, within our
sample, 21% of patients were transferred within 24 hours from a hospital offering no
PCTA to a hospital within our study that does, 6% were referred from a cardiologist at a
polyclinic within the first 24 hours.  
 
5. Box 2. Study timeline: In the end date of the 6 months follow-up, there is an obvious mistake
(Dec 2917).
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 Response: this has been corrected (page 6)
 
6. Figure 1 – an extra comma ”,” in the description of Selection.
Response: this has been corrected 
7. Page 5. What are the facilities for these four hospitals to perform PTCAs (which were not able to
perform PTCAs 24h)?
Response: They can provide thrombolysis. This has been clarified. The section now reads
“Twelve (75%) of the facilities can perform PTCAs, all 24 hours a day; the remaining four
are two small municipal hospitals in Samara, the regional cardiology hospital in Bryansk
and one of the hospitals in Tver, all of which are able to perform thrombolysis).”
 
8. Table 1. Although this table describes the overall characteristics of these hospitals and not
information on the study population, it would be informative to know the number of AMI patients in
these hospitals. We recommend stating more clearly that this table does not describe the study
population. It should be stated if the percentage of patients undergoing PTCA in this table refers to
these AMI patients hospitalized in first 24 hours from symptom onset or if it is the overall proportion
of performed PTCAs of all AMI or CHD patients.
Response: We have now added the number of AMI patients in 2015 and revised the text
for clarity. We have also revised the table heading.
 
9. Figure 3. The second box in the lower row: policlinic or polyclinic
Response: We now use Polyclinic throughout for consistency
 
10. Table 2. This table would benefit from some revision. It is somewhat confusing since there are
numbers and percentages in disorder although it is mentioned in the column label. Perhaps
percentage sign would clarify this.
 
The definitions of the categories “not meeting inclusion criteria”, “refused to participate”, and “died
before first contact” are unclear:
If a potentially eligible patient has died before the first contact, why he/she is not categorized
as a “not meeting inclusion criteria” patient (one of the inclusion criteria)?
I understand these columns so that “not meeting inclusion criteria” and “refused to
participate can be nested in some cases (Barnaul, Tuymen, Khanty-Mansiysk) or are the
values incorrect for these hospitals? (Tuymen: 6+13+20+112=151, not 149)
 Values for Barnaul do not tally (93*0.667=62 NOT 55).
Response: The table has been reformatted and updated. Since the first submission some
numbers have changed due to data cleaning. Now all the numbers sum to 100% and each
patient can be only in one category.  We have clarified the definitions in a footnote
11. Page 8, Progress with recruitment “The number from each region varied from 12 to…”. We
suppose the correct number is 7.
Response: We are referring to regions, not individual clinics here. Regionally, the lowest
Page 18 of 23
Wellcome Open Research 2018, 2:89 Last updated: 30 APR 2018
 Response: We are referring to regions, not individual clinics here. Regionally, the lowest
number was12 for the Saratov region7 it is the number from one clinic in Samara region,
but there are 3 clinics there and total number for Samara region is 128. As a result, these
 numbers are correct and have not been changed here. 
 
12. Analysis. Planned statistical methods to analyse this data are described only in the Abstract.
We are concerned whether the number of this dataset will be enough for the multilevel modelling.
There are only 7 cases in one region and 12 in the other and the number of covariate variables is
large. Have you done some preliminary analyses to ensure that multilevel modelling is feasible?
Response; We thank the reviewers for raising this concern. We are planning, at the very
least, multivariate analyses of the data. Multilevel modelling will form part of our analysis
strategy, only where it is possible and the results obtained are of substantive interest and
perform well in model diagnostic tests. Due to the nature of our data we absolutely do not
expect to be able to incorporate any random slopes, for example, and thus this is not
planned, we are most interested in a variance components (random intercept) model.
 We are interested in the use of a random intercept both technically (in accounting for
clustering and subsequent effects on precision of estimates) and substantively. We do
not wish to run multilevel models unnecessarily and will consider how to stratify the
sample for any multilevel analyses run to ensure they contribute to the overall aims of the
study. Were multilevel modelling deemed inappropriate once model diagnostics are
obtained we will look to the use of robust standard errors and/or fixed effects.  
However, from a statistical perspective, using standard ‘rules of thumb’ we agree that any
analyses with a regional intercept would more than likely require the exclusion of the
Saratov region from the analysis (the lowest total number of patients is 12 (the region of
Saratov) and we agree that this region would need to be excluded from any analyses that
involved a random intercept, similarly the Samara hospital with 7 cases (and Saratov with
12) would also be excluded. We will also be considering ability to check normality
assumption and non-zero variance when fitting these models, we strive to derive a
technically appropriate substantively insightful analysis and there is a process of iteration
in these planned analyses
We have adapted our references to the analysis strategy to highlight its multivariate
nature, and the implementation of multilevel modelling where possible and in line with our
 substantive aims.
 No competing interests were disclosed.Competing Interests:
 16 October 2017Referee Report
doi:10.21956/wellcomeopenres.13511.r26328
 Robert Clarke
CTSU (Clinical Trial Service Unit & Epidemiological Studies Unit), Nuffield Department of Population
Health, University of Oxford, Oxford, UK
The aim of this study is to publish a protocol for a study to evaluate the management of acute myocardial
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 1.  
2.  
3.  
4.  
5.  
6.  
7.  
8.  
9.  
10.  
The aim of this study is to publish a protocol for a study to evaluate the management of acute myocardial
infarction (MI) in Russia. The study has recruited individuals aged 35-70 years from 16 hospitals across
13 regions in Russia. Individuals have to survive 24 hours after admission with a confirmed diagnosis of
MI. The objectives of the study were to assess determinants of treatment decisions. Data were obtained
on 1122 patients and the protocol acknowledges that the sample is not representative.
 
 Major comments:
Criteria for diagnosis of MI should reference WHO criteria. The current description of criteria is
inadequate (e.g. no description of ST elevation, T-wave inversion, onset of Q-waves), elevated
plasma levels of cardiac enzyme, etc. It would be best to specify a gold standard and see how
many achieved this standard.
 
The impact of the requirement to survive 24 hours after presentation should be assessed.
 
It is unclear if only patients admitted to a coronary care unit or cardiology ward are eligible or
whether the study involves all wards in any one hospital.
 
The study mentions specialized cardiology departments and general hospitals with cardiology
departments, but does not specify if the difference is access to cardiac catheterization or cardiac
surgery or other criteria. Selection bias may be relevant in the analysis.  
 
Table 1 provides characteristics of 13 hospitals but does not involve number of beds (measure of
hospital size) or type of cardiology department (see Response 4.). Likewise, Table 1 should
include mean age of study participants as the mortality may vary if the study clinic involves an older
population.
 
Clarify what are polyclinic cardiologists (Box 3) and how these differ from cardiology departments.
 
The response rate was very low for Tver regional hospital, Rostov-on-Don and Saratov hospitals,
but the reasons are unclear. It is also unclear why 78% of patients attending Rostov-on-Don were
ineligible for the study. These discrepancies raise serious questions about the conclusions of this
study.
 
The study report has multiple small grammatical errors that should be corrected prior to publication
by careful review by a native English speaker. For example, the abstract includes a mixture of
present and past tense when it would be best to limit it to past tense.
 
The data extracted from medical records should be used to confirm the diagnosis of MI.
 
The study did not mention whether there were written (online) protocols in place for management
of AMI in some or all of these hospitals.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
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 1.  
2.  
3.  
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
 No competing interests were disclosed.Competing Interests:
Referee Expertise: Epidemiology of cardiovascular disease
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Author Response 18 Mar 2018
, therapy, Ivanovo state medical academy, Russian FederationAnna Kontsevaya
Criteria for diagnosis of MI should reference WHO criteria. The current description of criteria
is inadequate (e.g. no description of ST elevation, T-wave inversion, onset of Q-waves),
elevated plasma levels of cardiac enzyme, etc. It would be best to specify a gold standard
and see how many achieved this standard.
Response: we obviously failed to clarify the aims of the study, and as requested by
the other reviewer, have now done this. At the outset we felt that we could not be
sure what diagnostic criteria were being used in Russian hospitals. Thus, one of our
research questions was whether Russian clinicians were using WHO criteria. We
now have the information that will allow us to answer that question. A secondary
question was what happens to patients who have been given a diagnosis of AMI,
regardless of whether it meets WHO criteria. This will then allow us to assess
appropriateness of treatment. We hope we have now clarified this in the text.
 
The impact of the requirement to survive 24 hours after presentation should be assessed.
Response: The reviewer raises an important point but we believe that this would
require a separate study. It is important to reiterate that this is the first study ever,
to our knowledge, to study the management of AMI in Russian hospitals in a
standardized manner, using established instruments. Even getting to this stage has
been extremely challenging as there is very little (if any) tradition of health services
research in Russia outside a few centres in the main cities. Thus, even when we
have finished it there is a great deal that we will not know. The ideal way to answer
this question would be to look specifically at those dying within 24 hours after
admission, but this would require trained staff who could approach the families of
patients in their own homes and collect sensitive information. We have some
experience of doing this in our earlier research in Izhevsk, where we did collect data
from family members of men who had died, but that project, in a single city,
required a degree of effort that was an order of magnitude greater than what has
been available to us here, including intensive supervision to ensure quality.
 
It is unclear if only patients admitted to a coronary care unit or cardiology ward are eligible or
whether the study involves all wards in any one hospital.
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 3.  
4.  
5.  
6.  
7.  
Response: patients admitted to any ward of the clinic with primary diagnosis of MI
were eligible, The presence of this diagnosis inevitably led to hospitalization either
in a coronary care unit or an intensive care unit if one was unavailable. A sentence
clarifying this has been added to the ‘Study population and recruitment’ section on
pages 4-5.
 
The study mentions specialized cardiology departments and general hospitals with
cardiology departments, but does not specify if the difference is access to cardiac
catheterization or cardiac surgery or other criteria. Selection bias may be relevant in the
analysis.  
Response: The facilities have been selected to include a range of those that exist in
Russia. One of the questions we will be asking is to what extent the availability of
facilities influences practice, although we concede that the study has limited power
to go far in this direction. We are not sure if the reviewer means selection bias in
terms of who goes where. If so, we suspect this will not be an issue as in all but a
few very large cities there is no real choice. We have added a sentence on cardiac
surgery in the ‘selection and characteristics of facilities’ section on page 7
 
Table 1 provides characteristics of 13 hospitals but does not involve number of beds
(measure of hospital size) or type of cardiology department (see Response 4.). Likewise,
Table 1 should include mean age of study participants as the mortality may vary if the study
clinic involves an older population.
Response: We have added columns with numbers of number of beds (total and
cardiology) to Table 1. We have also added a separate, new tablewith mean (and
SD) age ( Table 3).
 
Clarify what are polyclinic cardiologists (Box 3) and how these differ from cardiology
departments.
Response: We realise that we should have clarified this and have added some
words. In brief, in Russia, there are physicians who have received training in a
speciality, but at a very basic level. They are employed in polyclinics but their skills
are not commensurate with what one would expect in the West and most would
have the training in a specialist area possessed by a GP elsewhere (but they would
not work outside that speciality). For example, they would undertake basic
assessments of ECGs etc. and provide medical management of angina. In contrast,
those working in cardiology departments in hospital would have a high level of
training, including in areas such as interventional cardiology (which is separate
subspecialty which requires separate training). We have now clarified this in box 3
(page 11)
 
The response rate was very low for Tver regional hospital, Rostov-on-Don and Saratov
hospitals, but the reasons are unclear. It is also unclear why 78% of patients attending
Rostov-on-Don were ineligible for the study. These discrepancies raise serious questions
about the conclusions of this study.
Response: We agree that this is a potential problem. We have been unable to elicit
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 7.  
8.  
9.  
10.  
Response: We agree that this is a potential problem. We have been unable to elicit
reasons for these differences and, once the data have been fully cleaned, we will
examine them carefully for any unusual features, as well as considering the use of
sensitivity analyses when we come to analyse the data.
 
The study report has multiple small grammatical errors that should be corrected prior to
publication by careful review by a native English speaker. For example, the abstract
includes a mixture of present and past tense when it would be best to limit it to past tense.
Response: We have been through the paper again carefully and we hope that any
issues have now been resolved. 
 
The data extracted from medical records should be used to confirm the diagnosis of MI.
Response: This is being done. We are sorry if we did not clarify this in the text,
which we now do. Figure 3 includes the point about hospital record extraction and
box 3 details of the data extracted.
 
The study did not mention whether there were written (online) protocols in place for
management of AMI in some or all of these hospitals.
Response: We agree that we should have mentioned this (in fact, we have another
paper under review which describes in detail the process by which guidelines have
been developed in Russia). The relevant document covering the period when these
patients were treated is the Federal clinical guideline approved by Ministry of health
in 2013. 
http://mzdrav.rk.gov.ru/file/mzdrav_18042014_Klinicheskie_rekomendacii_Ostryj_infarkt_miokarda.pdf
This has now been added.
 No competing interests were disclosed.Competing Interests:
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